norplant 6 x 36 mg implantaatti
bayer schering pharma oy - levonorgestrelum - implantaatti - 6 x 36 mg - levonorgestreeli
norplant 2 x 75 mg implantaatti
schering oy - levonorgestrelum - implantaatti - 2 x 75 mg - levonorgestreeli
ebvallo
pierre fabre medicament - tabelecleucel - lymphoproliferative disorders - ebvallo is indicated as monotherapy for treatment of adult and paediatric patients 2 years of age and older with relapsed or refractory epstein-barr virus positive post-transplant lymphoproliferative disease (ebv+ ptld) who have received at least one prior therapy. for solid organ transplant patients, prior therapy includes chemotherapy unless chemotherapy is inappropriate.
nulojix
bristol-myers squibb pharma eeig - belatacept - graft rejection; kidney transplantation - immunosuppressantit - nulojix, in combination with corticosteroids and a mycophenolic acid (mpa), is indicated for prophylaxis of graft rejection in adult recipients of a renal transplant.
kymriah
novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - muut antineoplastiset aineet - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.
noromectin 18.7 mg/g oraalipasta
norbrook laboratories (ireland) limited - ivermectin - oraalipasta - 18.7 mg/g - ivermektiini
tacni 0.5 mg kapseli, kova
teva sweden ab - tacrolimusum - kapseli, kova - 0.5 mg - takrolimuusi
tacni 1 mg kapseli, kova
teva sweden ab - tacrolimusum - kapseli, kova - 1 mg - takrolimuusi
tacni 5 mg kapseli, kova
teva sweden ab - tacrolimusum - kapseli, kova - 5 mg - takrolimuusi